Clinical Trials · NCT01011556
A Study for the Transdermal Application of Teriparatide
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 233
- Start date
- Nov 2009
- Locations
- 18 sites, 5 countries
- Primary endpoint
- Percent Change From Baseline in Lumbar Spine Bone Mineral Density (BMD) at 12 Months